Project Grant R01DK143249
- Federal Project Grant Award Summary Virginia Commonwealth University received a $931,500 Project Grant award on September 12, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct research through August 31, 2028. The project will integrate a Prescription Produce Program (PPP)—a community-based nutrition intervention providing health education, wellness...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the Regents of the University of Michigan a $779,978 Project Grant on September 6, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative, titled "Improving Diabetes Outcomes and Health Disparities by Addressing Unmet Resource Needs," will develop and test adaptive intervention sequences to address...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Pittsburgh a $343,954 Project Grant on September 13, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a pilot intervention study addressing health-related social needs (HRSN) in adolescents and young adults with Type 2 Diabetes (T2D). The project, titled ONWARD (Optimizing Navigation for Wellness and...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $188,632 to the University of Kansas Medical Center Research Institute on August 1, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a five-year project extending through July 31, 2030. Led by Dr. Daniel Tilden, MD, MPH, an endocrinologist and rural health services researcher, this project develops and pilot tests the Rural...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded the University of Illinois a $295,494 Project Grant on September 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant funds the ACCELERATED-T2D research initiative, which investigates disparities in treatment intensification patterns across socioeconomic status backgrounds in Type 2 Diabetes patients. The project...
- Federal Grant Award Summary The University of Michigan received a $769,155 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 12, 2025, through July 31, 2030. The award supports the Michigan Diabetes Project, a research initiative delivering a virtually administered, evidence-based Peer-Led Diabetes Self-Management Support (PLDSMS)...
- Federal Project Grant Award Summary Rush University Medical Center received a $942,000 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, effective September 16, 2025, through August 31, 2028, funds a feasibility study to develop and evaluate a primary care-based weight management intervention program for patients discontinuing anti-obesity...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded New York University School of Medicine a $158,943 Project Grant on July 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This five-year initiative, scheduled for completion by May 31, 2030, develops and tests a community health worker (CHW)-led intervention designed to support South Asian patients with Type 2 Diabetes who are at...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded The Regents of the University of Colorado–Denver a $756,480 Project Grant on September 5, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports a research initiative extending through June 30, 2030, that addresses critical evidence gaps in Type 2 Diabetes treatment by integrating real-world data from three health systems with...
- Federal Grant Award Summary Duke University received a $242,250 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded on August 12, 2025, with a completion date of July 31, 2027. This R03 award funds a mixed-methods research study designed to identify geographic "hot spots" for diabetes and peripheral artery disease (PAD)-related amputations...
Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $847,068 Project Grant to the University of Missouri at Kansas City on March 10, 2026, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The project, scheduled for completion by February 28, 2031, addresses food access and physical activity interventions to improve diabetes prevention outcomes among underserved African Americans. The research will deliver a cluster randomized controlled trial of an enhanced Diabetes Prevention Program (DPP) model that integrates culturally tailored healthy food delivery, on-site physical activity programming, and linkages to community food and activity resources for 408 pre-diabetic African American participants recruited from churches in high-risk communities. The enhanced DPP model builds upon prior pilot research to overcome social determinants that limit clinically meaningful weight loss in underserved populations. By combining structured dietary modifications, increased physical activity, and modest weight loss goals (5-7%) with culturally relevant adaptations—including language tailoring, culturally appropriate foods, religiosity, and community norms—the project aims to close the documented effectiveness gap where African American DPP participants experience only half the weight loss of white participants. Study participants will be randomized to either a standard, culturally tailored DPP or the enhanced DPP model, with extended support linkages designed to maintain intervention benefits beyond the formal study period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $847.1k | 3/9/26 |